Introduction
Ultrafiltration of blood is perhaps the most important function of kidneys and is accomplished by glomeruli. Hence, the disorders of glomerular structure and function constitute one of the major problems encountered in nephrology practice. The term glomerulonephritis (GN) denotes an inflammatory process involving glomeruli and forms a large and an important group of kidney diseases in man. Glomerulonephritis can occur as a primary disease process involving kidney or can occur in association with systemic disorders. Studies in experimental models as well as widespread use of percutaneous renal biopsy have uncovered to a great extent, the spectrum of glomerulopathic processes and have provided new insights into various possible pathogenic mechanisms initiating and propagating glomerular injury. Eventually, evidence has accumulated over the past few years which suggests that autoimmunity is more widely involved in the pathogenesis of nephritis than previously realized. Consequently, a number of auto-antigens in various renal disorders have been identified. Some of them are listed in Table I . However, the pathogenic role of most of these antigens and of the antibodies against them has not yet been elucidated. Nevertheless, some of them have proven to be important markers of disease activity as well as indices to disease prognosis. Analysis of the autoantibodies can also aid in early, as well as differential, diagnosis of several glomerulonephritides. In the present review, autoantibodies associated with various glomerulonephritis in humans will be discussed.
The classical anti-GBM antibody-induced glomerulonephritis
The classical example of antibody-mediated glomerulonephritis is Goodpasture syndrome, a term coined by Stanton and Tange in 1958' in recognition of a patient described in 1919 by E.W. Goodpasture.2 This disorder consists of a triad of findings: pulmonary haemorrhage, glomerulonephritis and antibodies to the glomerular basement membrane (GBM). It typically affects young individuals but may appear at any age. Pulmonary haemorrhage may be severe and life threatening or may be extremely mild and easily overlooked. Rapidly progressive glomerulonephritis is the most common clinical feature of the syndrome.3 '4 Light microscopic studies of renal biopsy most often reveal an extensive extracapillary proliferation (crescents) in glomeruli while immunofluorescence studies show typical linear deposits of IgG along the GBM.3 '4 Circulating anti-GBM antibodies are found in over 90% of patients if sera are examined early in the course of the disease by sensitive immunoassays.35 Anti-GBM antibodies can also be eluted from kidneys of such cases using appropriate techniques.346 Most often the disease is progressive, occasionally fulminant, leading to irreversible renal failure and sometimes death despite active treatment.
Traditionally the diagnosis of Goodpasture syndrome is confirmed by the finding of linear deposits of immunoglobulins along the GBM on direct immunofluorescence examination.7 Although fairly simple, it is time consuming and difficulties in interpretation can arise in relatively damaged tis- of type IV collagen in the GBM""2 ( Figure 1 ).
Identification of the antigen involved in Goodpasture syndrome has prompted the development of a highly sensitive, specific and rapid ELISA for the diagnosis of Goodpasture syndrome. 5 The assay can be completed in 30 minutes thus permitting early commencement of specific therapy comprising plasma exchange'3 or protein A immuno-adsorption,'4"15 especially in severely ill patients and contributing to regression in morbidity and mortality from the disease.
Other anti-GBM antibody-associated glomerulonephntides Although several glomerular antigens have been described in experimental glomerulonephritis in animals; such as 330K and 90K glycoproteins (gp330 and gp9O) in Heymann nephritis,'6"18 laminin and collagen IV in mercuric chloride-induced nephritis in rats" and laminin in murine model of graft versus host (GvH) disease,20 the role of possible antigenic determinants of the GBM, other than the Goodpasture antigen, in the pathogenesis of anti-GBM glomerulonephritis remains undefined.9,10,21
Lately, we discovered a middle-aged male patient with a mild form of glomerulonephritis. Direct immunofluorescence examination of the kidney biopsy specimen revealed weak linear immune deposits along the GBM. The patient possessed circulating antibodies directed against the NCl domain of type IV collagen ( Figure 1 ) but not to the a3 (IV) antigen (Goodpasture antigen). Instead, the antibodies reacted to another subunit in the NCl region namely ml (IV). This suggests that anti-NC1 antibodies that are not directed against the Goodpasture antigen a3 (IV) can be associated with glomerulonephritis in humans. However, they are accompanied by trivial renal damage and possibly lead to milder variants of anti-GBM nephritis (Johansson, C. et al., in preparation).
Recently, we observed that almost 40% of more than 200 patients with different types of biopsyverified glomerulonephritis possessed antibodies directed against antigens present in crude 6M guanidine-HCI extract of GBM.22 Since the crude extract contains a variety of glycoproteins, each one of which could be a potential auto-antigen, it was interesting to isolate these proteins and study the fine specificity of antibodies against them. In this process we isolated entactin (nidogen),23-29 a 150 kD dumbbell-shaped GBM glycoprotein that reacted, in a definite pattern, with sera from several patients with glomerulonephritis in a renal biopsy series. 30 Two distinct groups of patients with antientactin antibodies were identified. The larger group consisted of young patients (peak incidence 18-30 years) with primary mesangio-proliferative glomerulonephritis associated with significant proteinuria which responded poorly to steroids and immunosuppressive treatment. The other group comprised middle-aged patients (peak incidence 51 -60 years) with glomerulonephritis secondary to SLE or SLE-like collagen vascular disease with a milder degree of proteinuria which was well responsive to therapy.30 A highly significant correla-tion was also observed between the presence of circulating anti-entactin antibodies and the deposition of a corresponding class of immunoglobulins along the GBM on immunofluorescence examination. However, most of these patients had granular immune deposits along the GBM which would traditionally classify them as having immune complex disease. Studies in experimental models of autoimmune nephritis such as mercuric chlorideinduced nephritis in Brown Norway rats'9'3 and the murine model oflupus nephritis20'32 have shown the presence of anti-GBM antibodies that are deposited initially in a linear fashion along the GBM but gradually their pattern becomes granular probably because of the reorganization of the antigen-antibody complexes. Such a phenomenon possibly also exists in humans but will require early as well as sequential renal biopsies for its elucidation. Nevertheless, the observations in experimental models implicate that anti-GBM glomerulonephritis can have granular immune deposits along the GBM, which is probably the case with patients possessing circulating anti-entactin antibodies.
To summarize, our observations suggest that entactin may be involved in the pathogenesis of certain forms of glomerulonephritis (non-Goodpasture anti-GBM nephritis) in humans. As one group of patients with anti-entactin antibodies comprises young individuals with relatively severe and progressive disease, identification of such patients may have diagnostic and therapeutic implications. 
Anti-neutrophil cytoplasm antibodies (ANCA) -associated glomerulonephritis
The association of ANCA with vasculitis and glomerulonephritis has opened new vistas to study pathogenic mechanisms involved in glomerulonephritis. These auto-antibodies which are directed against the constituents of primary (a or azurophilic) granules of human neutrophils and monocyte lysosomes (ANCA) were first described in patients with necrotizing glomerulonephritis and clinical evidence of primary small vessel vasculitis in 1982. 43 The auto-antibodies were detected by indirect immunofluorescence staining of ethanolfixed normal human neutrophils. Since then, two main fluorescence patterns have been characterized. One is a distinct cytoplasmic staining with accentuation at the centre (c-ANCA) while the other is a peripheral perinuclear or nuclear staining (p-ANCA).4 c-ANCA and p-ANCA react with neutrophils and monocytes but not with mature macrophages, lymphocytes or eosinophils.
The c-ANCA antigen is a 29 kD protein present in a granules and lysosomes of neutrophils and monocytes respectively.45 N-terminal sequencing of this 29 kD antigen has revealed that this target antigen is proteinase 3 (PR 3), a recently described human leukocytic serine protease.' It is identical with myeloblastin, a serine protease that is present in promyelocyte-like leukemia cell line HL-60. 47 The p-ANCA antigen is, in 80-90% of cases, found to be the enzyme myeloperoxidase (MPO 52 Although pathogenicity of ANCA has not been proven so far, several experimental models suggest a pathophysiological role of these antibodies.53 It has been shown that activated neutrophils are involved in the pathophysiology of necrotizing glomerulonephritis by releasing proteolytic enzymes and free oxygen radicals.54 However, under normal circumstances, these proteolytic enzymes are inactivated rapidly by protease inhibitors present in blood. It is assumed that ANCA form complexes with lysosomal enzymes and protect them from proteolytic degradation. The complexes might then be transported to other areas such as kidney and trapped there. If proteinases in these complexes retain their activity, they might then cause local damage.53 '54 Analysis of ANCA has proven to be of immense value in early diagnosis of patients with rapidly progressive GN and GN associated with systemic vasculitis. As in the case with Goodpasture syndrome, early diagnosis of ANCA-associated disorders can vastly improve the outcome of these otherwise rapidly progressive medical emergent conditions.
Analysis of ANCA also facilitates differential diagnosis and sub-classification of patients with extracapillary GN. This is exemplified by 16 cases who presented with haemoptysis and rapidly progressive glomerulonephritis (clinically as Goodpasture syndrome). In fact, a majority of them (9 patients) did not have anti-GBM (anti-NC1) antibodies but had ANCA. These findings have clinical implications since anti-NC1 antibodies are associated with more severe disease and require more intensive management than those with ANCA.5'
Auto-antibodies against C3b convertase in glomerulonephritis
IgG auto-antibodies to C3 convertase of the alternative complement pathway (C3bBb) have been discovered recently in several patients with hypocomplementemic membranoproliferative GN (MPGN). These autoantibodies are called C3 nephritic factor (C3NeF).5557 C3NeF stabilizes the labile C3bBb from inactivation, thus resulting in an increased degradation of C3.55-57 This in turn results in depression of haemolytic complement activity of the serum accompanied by low C3 levels in patients with MPGN. However, C3 levels can be normal when C3NeF is present in a high concentration and vice versa. [55] [56] [57] Not all patients with MPGN possess C3NeF. It is more common in patients with type II MPGN than in patients with type 1.55,57.58 It has also been found in some cases of secondary MPGN particularly in patients with SLE, shunt nephritis and idiopathic cryoglobulinemia.55 There is no direct relationship between the levels of C3NeF and renal damage nor is there any correlation between the presence of C3NeF and disease activity.55,57,58
The role of C3NeF in the pathogenesis of MPGN is questionable and it should only be considered as a marker of a subset of MPGN. 55'57'58 Other auto-antibodies in human nephritis Auto-antibodies in post-streptococcal glomerulonephritis Recently, Fillit et al.59 demonstrated that sera from patients with acute post-streptococcal GN (APSGN) contain antibodies directed against heparan sulphate proteoglycans ofthe GBM. Kefalides et al.%extended these observations by showing that these sera not only react with heparan sulphate proteoglycans but also with laminin and collagenase-resistant fragment of type IV collagen corresponding to the 7S region ( Figure 1) . No reaction was observed against fibronectin. They suggested that tissue injury occurring in post-streptococcal GN can release antigen fragments from critical tissue regions into circulation, leading to development of specific auto-antibodies. However, another possibility remains that auto-antibodies in post-streptococcal glomerulonephritis are developed against cross-reactive determinants shared by streptococcus and basement membrane antigens. These cross-reactive determinants need necessarily not be proteins but may also represent cross-reactive carbohydrate epitopes.5960 However, the pathogenic or diagnostic significance of these autoantibodies in APSGN remains unexplored.
Streptococcal neuraminidase activity has also been held responsible for development of autoimmune reactivity in APSGN.6' Neuraminidase reacts with sialic acid-rich sites found on immunoglobulins and glomerular capillary epithelial and endothelial cells.61~" Sialic acid depletion from these sites may evoke autoimmune response resulting in formation of anti-immunoglobulins (rheumatoid factors) and possibly, antibodies against yet unidentified glomerular antigens. 6 
Summary
Autoimmunity is now unequivocally regarded as the predominant pathogenic process underlying most forms of primary and secondary glomerulonephritis in humans. Most of the investigations so far have been focused upon humoral mechanisms. Consequently, the role of cell-mediated immunity in nephritis is still incompletely understood. Nonetheless, as a result of contemporary studies, a number of previously unidentified auto-antibodies in association with glomerulonephritis have been discovered. However, apart from anti-NC1 antibodies in the classical Goodpasture syndrome, the exact role of these auto-antibodies in the pathogenesis of glomerulonephritis yet remains undefined. This fact, however, does not undermine the relevance of exploring these auto-antibodies. They have been of immense help in sub-classifying glomerulonephritis previously thought homogeneous ( Figure 3) . Besides, analysis of autoantibodies has assisted tremendously in the early diagnosis of rapidly progressive glomerulonephritis. This, in turn, has aided in early commencement of therapy thus contributing to regression in morbidity and mortality resulting from these disorders. Moreover, investigation of these autoantibodies is of enormous value for future studies aimed at understanding the pathogenic mechanisms involved in glomerulonephritis.
